English (United Kingdom)German formal - Sie Greek
Font Size Larger Font Smaller Font

Eine vielversprechende neue Behandlungsoption

Bitte sehen Sie diesen Abschnitt des Öfteren auf aktuelle Berichte, Branchenveranstaltungen und unsere jüngsten Medienressourcen ein.


British and Eire Association of Vitreoretinal Surgeons (BEAVRS)
7. – 8. November 2013 | Bristol, England

American Academy of Ophthalmology 2013 Annual Meeting (AAO)
16. – 19. November 2013 | New Orleans, LA USA
Oraya Therapeutics Booth #2363 Hall F


Mittwoch, 25. September 2013 | Oraya Therapeutics, Inc. announced today the two-year results of its INTREPID study of Oraya Therapy™ Stereotactic Radiotherapy for the treatment of wet age-related macular degeneration (AMD)…More >

Mittwoch, 14. August 2013 | Oraya Therapeutics, Inc. announced today that the Oraya Therapy™ Stereotactic Radiotherapy for the treatment of wet age-related macular degeneration (AMD) is now available at Optegra Manchester Eye Hospital…More >

Donnerstag, 18. April 2013 | Oraya Therapeutics, Inc. today announced that results of its INTREPID study evaluating the safety and efficacy of Oraya Therapy™ Stereotactic Radiotherapy…More >

Donnerstag, 4. April 4 2013 | New Therapy for Wet AMD Introduced in Switzerland by Oraya® Therapeutics and EyeRAD…More >

Mittwoch, 27. Februar 2013 | Oraya Therapy™ Continues to Show Efficacy for Wet Age-Related Macular Degeneration…More >


2. Oktober 2013 | eyewireTV Weekly
Two-year results of Oraya Therapeutics’ INTREPID study are presented, showing that radiation therapy for wet AMD is safe and effective.

25. September 2013 | eyewireToday
Oraya Therapeutics INTREPID Study Demonstrates 2-year Safety and Effectiveness of Non-invasive Therapy for Wet AMD.

September 2013 | EUROTIMES Seminar Supplement 12th EURETINA Congress
Oraya Therapy – A Significant Advance in the Treatment of Wet AMD

30. September 2013 | Readers Digest
This Won’t Hurt A Bit

Juni/Juli 2013 | Vision Magazine, Issue 60
Radiotherapy breakthrough to treat wet AMD

18. April 2013 | The Wall Street Journal
Oraya Therapeutics’ INTREPID Study Published in Ophthalmology, the Official Journal of the American Academy of Ophthalmology

1. April 2013 | New Retina MD
Radiation Therapy for Neovascular Age-related Macular Degeneration

4. März 2013 | Mail Online
The X-ray beam that could end painful jabs for aging eyes

1. März 2013 | Ophthalmology Times
INTREPID identifies ‘best responders’: Fewer anti-VEGF injections among benefits of stereotactic radiotherapy for wet AMD

27. Februar 2013 | Insight Radio
Revolutionary Treatment for AMD Launched

26. Februar 2013 | Yahoo!7 News
Hope for eye disease sufferers

25. Februar 2013 | ITV
New hope for macular degeneration

11. Februar 2013 | SMT Online
OnCore Opens Medical Center-of-Excellence

Präsentiert auf dem 2012 AAO-APAO Joint Meeting
IRay Plus Anti-VEGF Treatment for Patients with Wet Age-Related Macular Degeneration: The INTREPID Trial of Stereotactic Radiotherapy for Choroidal Neovascularization in AMD
Peter K. Kaiser, MD View Video >